Terms: = Lung cancer AND CgA
196 results:
1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of immune checkpoint inhibitors in SMARCA4-deficient and TP53 mutant undifferentiated lung cancer.
Chen J; Zheng Q; Wang J; Zhang X; Lv Y
Medicine (Baltimore); 2024 Feb; 103(8):e36959. PubMed ID: 38394494
[TBL] [Abstract] [Full Text] [Related]
3. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological features, treatment modalities, and prognosis of esophageal neuroendocrine carcinoma: A single-center retrospective study.
Zhang Y; Liao JT; Lin Y; Liu C; Wu ZH; Yu B; Sun S; Yu H; Hui XH; Wu XH; Zhao XM; Wang HJ; Zheng Q; Li Y; Hu ZH; Wang JL
J Dig Dis; 2023; 24(8-9):472-479. PubMed ID: 37596865
[TBL] [Abstract] [Full Text] [Related]
6. The effect of comprehensive geriatric assessment on care received, treatment completion, toxicity, cancer-related and geriatric assessment outcomes, and quality of life for older adults receiving systemic anti-cancer treatment: A systematic review.
Disalvo D; Moth E; Soo WK; Garcia MV; Blinman P; Steer C; Amgarth-Duff I; Power J; Phillips J; Agar M
J Geriatr Oncol; 2023 Nov; 14(8):101585. PubMed ID: 37573197
[TBL] [Abstract] [Full Text] [Related]
7. Hospitalization due to adverse drug events in older adults with cancer: A retrospective analysis.
Walsh DJ; Sahm LJ; O'Driscoll M; Bolger B; Ameen H; Hannan M; Goggin C; Horgan AM
J Geriatr Oncol; 2023 Jul; 14(6):101540. PubMed ID: 37295287
[TBL] [Abstract] [Full Text] [Related]
8. Metastases to the kidney from primary lung cancer : clinicopathological analysis of six cases in a single center.
Lian H; Pan X; Hong B; Min J; Huang F
Diagn Pathol; 2023 May; 18(1):60. PubMed ID: 37161448
[TBL] [Abstract] [Full Text] [Related]
9. [Mucinous tubular and spindle cell carcinoma of kidney: Clinicopathology and prognosis].
Shen Q; Liu YX; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):276-282. PubMed ID: 37042138
[TBL] [Abstract] [Full Text] [Related]
10. Intrathyroid thymic carcinoma: clinicopathological features and whole exome sequencing analysis.
Li J; Xiang R; Li Y; Liao Q; Liu Y
Virchows Arch; 2023 May; 482(5):813-822. PubMed ID: 37016248
[TBL] [Abstract] [Full Text] [Related]
11. The prognostic value of comprehensive geriatric assessment on the management of older patients with small cell lung cancer.
Chun YJ; Kim KJ; Lee JY; Choi JW; Kim TH; Kim HR; Cho BC; Hong MH; Kim CO
Korean J Intern Med; 2023 Mar; 38(2):254-263. PubMed ID: 36650729
[TBL] [Abstract] [Full Text] [Related]
12. Plasma Progastrin-Releasing Peptide and Chromogranin A Assays for Diagnosing and Monitoring lung Well-Differentiated Neuroendocrine Tumors: A Brief Report.
Nisman B; Oleinikov K; Nechushtan H; Maimon O; Atlan K; Peled N; Gross D; Peretz T; Meirovitz A; Grozinsky-Glasberg S
J Thorac Oncol; 2023 Mar; 18(3):369-376. PubMed ID: 36503175
[TBL] [Abstract] [Full Text] [Related]
13. Optimal Combination of Neuroendocrine Markers for the Detection of High-Grade Neuroendocrine Tumors of the Sinonasal Tract and lung.
Weissferdt A; Sepesi B; Ning J; Hermsen M; Ferrarotto R; Glisson B; Hanna E; Bell D
Curr Oncol Rep; 2023 Jan; 25(1):1-10. PubMed ID: 36422794
[TBL] [Abstract] [Full Text] [Related]
14. Pulmonary Large Cell Neuroendocrine Carcinoma.
Yang L; Fan Y; Lu H
Pathol Oncol Res; 2022; 28():1610730. PubMed ID: 36304941
[TBL] [Abstract] [Full Text] [Related]
15. The association between geriatric assessment, muscle measures, and treatment-related toxicity in older adults with cancer: An Israeli prospective study.
Shachar SS; Bar-Sela G; Peer A; Moskovitz MT; Bareket-Samish A; Epstein J; Wollner M; Shafran I; Boukal A; Williams GR
J Geriatr Oncol; 2022 Nov; 13(8):1203-1207. PubMed ID: 35989184
[TBL] [Abstract] [Full Text] [Related]
16. [On detection of chromogranin A, synaptophysin, neuronspecific enolase and progastrin-releasing peptide in small cell lung cancer].
Lu QQ; Li J; Li YH; Liu H; Xie XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jul; 56(7):1017-1022. PubMed ID: 35899358
[TBL] [Abstract] [Full Text] [Related]
17. Pro-Gastrin-Releasing Peptide as a Marker of Small Cell lung cancer.
Lyubimova NV; Kuz'minov AE; Markovich AA; Lebedeva AV; Timofeev YS; Stilidi IS; Kushlinskii NE
Bull Exp Biol Med; 2022 Jun; 173(2):257-260. PubMed ID: 35737164
[TBL] [Abstract] [Full Text] [Related]
18. Multiple primary pulmonary meningioma: A case report and literature review.
Huang X; Mou YF; Ren FQ; Wang Y; Yang Y
Thorac Cancer; 2022 Aug; 13(15):2257-2259. PubMed ID: 35734847
[TBL] [Abstract] [Full Text] [Related]
19. cancer germline antigen gene MAGEB2 promotes cell invasion and correlates with immune microenvironment and immunotherapeutic efficiency in laryngeal cancer.
Cui J; Chen Y; Ou Y; Liu G; Wen Q; Zhu W; Liang L; Chen Z; Yang H; Wang L; Wei M
Clin Immunol; 2022 Jul; 240():109045. PubMed ID: 35618211
[TBL] [Abstract] [Full Text] [Related]
20. Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
Wang Y; Chen Y; Yang Z; Qian F; Hu M; Lu J; Zhang Y; Zhang W; Wang K; Han B
Ann Surg Oncol; 2022 Sep; 29(9):5666-5678. PubMed ID: 35543906
[TBL] [Abstract] [Full Text] [Related]
[Next]
